Home/Filings/4/0001209191-09-051067
4//SEC Filing

CHEELEY C RON 4

Accession 0001209191-09-051067

CIK 0000310158other

Filed

Nov 3, 7:00 PM ET

Accepted

Nov 4, 5:51 PM ET

Size

28.4 KB

Accession

0001209191-09-051067

Insider Transaction Report

Form 4
Period: 2009-11-03
CHEELEY C RON
Senior Vice President
Transactions
  • Disposition to Issuer

    Option (right to buy)

    2009-11-03180,0000 total
    Exercise: $19.23Exp: 2013-05-18Common Shares (180,000 underlying)
  • Disposition to Issuer

    Option (Right to Buy)

    2009-11-0374,1730 total
    Exercise: $18.20Exp: 2014-02-22Common Shares (74,173 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2009-11-03179,3620 total
    Exercise: $20.70Exp: 2015-04-24Common Shares (179,362 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2009-11-03150,0000 total
    Exercise: $31.57Exp: 2014-04-30Common Shares (150,000 underlying)
  • Disposition to Issuer

    Phantom Stock Unit

    2009-11-0367,062.690 total
    Common Shares (67,062.69 underlying)
  • Disposition to Issuer

    Common Shares

    2009-11-0349,4600 total
  • Disposition to Issuer

    Common Shares

    2009-11-03646.710 total(indirect: By 401(k))
  • Disposition to Issuer

    Option (right to buy)

    2009-11-0330,0000 total
    Exercise: $16.62Exp: 2013-07-31Common Shares (30,000 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2009-11-03116,5000 total
    Exercise: $22.91Exp: 2016-04-30Common Shares (116,500 underlying)
  • Disposition to Issuer

    Option (right to buy)

    2009-11-03110,0000 total
    Exercise: $18.85Exp: 2015-04-30Common Shares (110,000 underlying)
Footnotes (6)
  • [F1]Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash.
  • [F2]In connection with the Merger, each share held in the Issuer's stock fund of the Issuer's 401(k) plan was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Both the shares and cash will remain in the plan until such time as the reporting person elects a distribution therefrom.
  • [F3]The options vested and became exercisable on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or the reporting person's termination of employment thereafter.
  • [F4]Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
  • [F5]Each unit of phantom stock is the economic equivalent of one share of common stock.
  • [F6]In connection with the Merger, each unit of phantom stock was converted into 0.5767 phantom shares of Merck & Co., Inc. common stock and $10.50 in cash. The cash value of the phantom stock units will be paid to the reporting person in accordance with the reporting person's distribution election under the Issuer's nonqualified deferred compensation plan.

Issuer

Merck & Co. Inc.

CIK 0000310158

Entity typeother

Related Parties

1
  • filerCIK 0001256917

Filing Metadata

Form type
4
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 5:51 PM ET
Size
28.4 KB